Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

M&A

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • M&A
  • News
  • Politics

“Nippon Steel Sends Delegation To Washington To Gauge U.S. Steel Deal; Steel Is Very Important To National Security, Says White House Adviser Brainard” – Nikkei Asia

By Benzinga Newsdesk
January 23, 1:58 PM
https://asia.nikkei.com/Economy/Trade/Nippon-Steel-sends-delegation-to-Washington-to-gauge-U.S.-Steel-deal  WASHINGTON -- Nippon Steel sent a delegation to Washington last week to meet with lawmakers and think

EWJ

Read More
1 minute read
  • M&A
  • News

Naya Biosciences To Acquire Florida Biotechnologies For $20M Shares Of NAYA Post-Merger With INVO; Florida Biotechnologies Eligible For Additional $5M Upon Certain Milestones Achievement

By Benzinga Newsdesk
January 23, 9:47 AM
NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in 28-patient clinical trialProgram developed by Florida Biotechnologies, Inc. & the University of Miami's

INVO

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Trading Ideas

French Drugmaker Sanofi Agrees To Buy Inhibrx’s Candidate For Rare Genetic Indication, For About $2.2B

By Vandana Singh
January 23, 9:00 AM
Sanofi's strategic acquisition of Inhibrx's INBRX-101, a alpha-1 antitrypsin therapy in a registrational trial. Learn about the $2.2B merger details and Inhibrx Biosciences' spin-off. Closing expected in Q2 2024.

INBX

Read More
2 minute read
  • Legal
  • M&A
  • News

On Jan 22, Six Flags Entertainment Corp And Cedar Fair Each Received A Request For Additional Information And Documentary Materials From DOJ

By Benzinga Newsdesk
January 23, 8:55 AM
- SEC FilingAs previously announced, on November 2, 2023, Cedar Fair, L.P., a Delaware limited partnership ("Cedar Fair") entered into an Agreement and Plan of Merger (the "Merger Agreement" and the transactions

FUN

Read More
2 minute read
  • General
  • M&A
  • News

Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project

By Benzinga Neuro
January 23, 8:46 AM
Following the acquisition, New Inhibrx will continue to operate under the "Inhibrx" name, with Mark Lappe as Chairman and CEO.

INBX

Read More
2 minute read
  • Contracts
  • Equities
  • General
  • Large Cap
  • M&A
  • News

From Wind To Watts: TotalEnergies Makes Waves In European Offshore With New Buyout & Deal

By Lekha Gupta
January 23, 8:15 AM
TotalEnergies acquires German battery storage developer Kyon Energy and expands offshore wind projects in Denmark, Finland, and Sweden.

TTE

Read More
1 minute read
  • M&A
  • News

Inhibrx Sells INBRX-101 To Sanofi For Up To $2.2B, Spins Off New Company With All Non-101 Assets And Liabilities

By Benzinga Newsdesk
January 23, 2:09 AM
Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares in New Inhibrx, a new publicly traded company that retains all non-101 assets

INBX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • M&A
  • News
  • Top Stories

Comerica Analyst No Longer Bullish, Sees ‘Attractive Attributes In Coming M&A Cycle’

By Priya Nigam
January 22, 1:15 PM
Shares of Comerica Incorporated (NYSE: CMA) fell in premarket trading on Monday, after the company last week reported its fourth-quarter earnings.

CMA

Read More
2 minute read
  • Analyst Ratings
  • Government
  • M&A
  • News
  • Regulations
  • Reiteration
  • Tech
  • Trading Ideas

Roomba Maker iRobot Struggles with Potential EU Rejection of Amazon Acquisition and Falling Sales, Analyst Says

By Anusuya Lahiri
January 22, 1:04 PM
IRobot (NASDAQ: IRBT) stock fell to 52-week lows as EU regulators may reject Amazon's planned acquisition. Analyst expects $94M if deal breaks.

AMZN

Read More
1 minute read
  • Asset Sales
  • Equities
  • Guidance
  • M&A
  • Mid Cap
  • Movers
  • News

Why NuStar Energy Shares Are Rocketing Today

By Lekha Gupta
January 22, 12:39 PM
NuStar Energy's shares surge as Sunoco announces a $7.3 billion all-equity acquisition. NuStar common unitholders will receive 0.400 Sunoco common units for each NuStar common unit, implying a 24% premium based on the 30-day VWAP as of January 19, 2024.

NS

Posts pagination

Previous 1 … 64 65 66 … 448 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service